Allianca Saude e Participacoes S.A. Stocks

R$ 4.3Last Updated 22.12.2025

Issuer Rating

3/7

Performance

Average

Risk

High

Recommendation

Sell

Market Cap

R$ 109.10M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
R$ 4.3
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Alliança Saúde e Participações SA operates as a holding company, which engages in the provision of medical diagnostic services. It offers imaging and chart-based diagnosis, nuclear medicine and cytology, pathological anatomy, and clinical tests. The company was founded by Geraldo Mol Starling Filho on August 5, 1992 and is headquartered in Sao Paulo, Brazil.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is 'cheap' on EV/EBITDA, overvalued on P/FC.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks